I have done a fair bit of research into this company and was pleased to see the price target of $1.62 by arrowhead the other day. However it seems very hard to gauge how this technology compares to other similar systems.
The company fundamentals look good but the risk profile is so unknown to me. Why wouldn't another biotech company (perhaps a much larger one) with greater resources be able to produce a better system?
If this does turn out to be the best system on the market then one could foresee this company being a multi multi bagger. Is this risk priced in?
Add to My Watchlist
What is My Watchlist?